Cardium Therapeutics is currently exhibiting its new FDA-cleared Excellagen^® professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds at the 2012 Spring Symposium on Advanced Wound Care (SAWC) being held April 19 – 22, 2012 in Atlanta, GA.

(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

The 2012 Spring SAWC provides Cardium an opportunity to showcase its Excellagen high molecular weight formulated fibrillar collagen-based topical gel to the more than 2,000 attendees including physicians, podiatrists, nurses, therapists and researchers. Medical professionals can learn more about Excellagen by visiting us at Booth 247 or contacting Sarah Dennison at [email protected].

Let us hear your thoughts below.